New app could cut phone calls for cancer patients
NCT ID NCT06371911
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a digital platform called Cureety could reduce the number of phone calls hospital staff need to make to cancer patients before their injectable treatments. 192 adults starting injectable cancer therapy in France were randomly assigned to usual care or usual care plus Cureety. The platform lets patients report symptoms and test results online, potentially flagging only those who need a call.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cureety telemonitoring platform
What this could lead to
If successful, this could reduce hospital staff workload and improve patient convenience during cancer treatment monitoring.
What could go wrong
This is a completed study, but the results are not yet widely known. The benefit may be limited to patients comfortable with technology.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre François Baclesse
Caen, 14000, France
-
Centre de Radiothérapie et Oncologie Médicale d'Osny
Osny, France
-
Centre hospitalier de Bligny
Bligny, France